Knockdown of circ-TTBK2 Inhibits Glioma Progression by Regulating miR-1283 and CHD1.
OA: gold
CC-BY-NC-4.0
Abstract
BackgroundDysregulated circular RNAs (circRNAs) are involved in the development of glioma. This paper aims to analyze the role and mechanism of circRNA tau tubulin kinase 2 (circ-TTBK2) in glioma progression.MethodsThe glioma samples and normal brain tissues were collected. The levels of circ-TTBK2, microRNA-1283 (miR-1283) and chromodomain helicase DNA-binding protein 1 (CHD1) were examined via quantitative reverse transcription polymerase chain reaction or Western blot. Cell proliferation, migration, invasion and glycolysis were determined via 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide, transwell assay, Western blot, glucose and lactate assay kits. The target relationship was analyzed via dual-luciferase reporter assay. The xenograft model was established using U251 cells.Resultscirc-TTBK2 expression was increased in glioma tissues and cells. circ-TTBK2 knockdown suppressed glioma cell proliferation, migration, invasion and glycolysis. circ-TTBK2 was a sponge for miR-1283, and knockdown of miR-1283 reversed the effect of circ-TTBK2 silence on glioma progression. CHD1 was targeted via miR-1283, and miR-1283 repressed glioma cell proliferation, migration, invasion and glycolysis via decreasing CHD1. Knockdown of circ-TTBK2-reduced CHD1 expression by mediating miR-1283. Silence of circ-TTBK2 reduced xenograft tumor growth.ConclusionDown-regulation of circ-TTBK2 suppressed glioma development by regulating miR-1283 and CHD1, providing a new mechanism for understanding glioma pathogenesis.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (28)
- Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo via crossref
- doi:10.1007/s00401-017-1671-4 via crossref
- doi:10.1093/neuonc/nou147 via crossref
- doi:10.3390/ijms19041115 via crossref
- doi:10.1007/s11912-017-0637-y via crossref
- doi:10.3390/ncrna5020036 via crossref
- doi:10.20892/j.issn.2095-3941.2018.0425 via crossref
- doi:10.1186/s13024-018-0237-9 via crossref
- doi:10.1111/febs.14866 via crossref
- doi:10.1186/s13045-017-0422-2 via crossref
- doi:10.3390/cancers9070085 via crossref
- doi:10.1371/journal.pone.0159171 via crossref
- doi:10.1177/1177932217694837 via crossref
- doi:10.3727/096504018x15251282086836 via crossref
- doi:10.1093/nar/gky128 via crossref
- doi:10.1111/cpr.12700 via crossref
- doi:10.1006/meth.2001.1262 via crossref
- doi:10.1038/nrc3090 via crossref
- doi:10.1038/nrclinonc.2016.26 via crossref
- doi:10.1186/s12943-016-0502-x via crossref
- doi:10.3390/molecules21121730 via crossref
- doi:10.1016/j.tins.2012.05.001 via crossref
- doi:10.1007/s11060-018-2757-0 via crossref
- doi:10.1186/bcr3644 via crossref
- doi:10.3892/or.2017.5780 via crossref
- doi:10.3727/096504018x15178768577951 via crossref
- doi:10.1016/s0140-6736(18)30990-5 via crossref
- doi:10.3390/molecules23051072 via crossref
Source provenance
- crossref
- last seen: 2026-07-03T07:19:15.269270+00:00
- europepmc
- last seen: 2026-07-16T06:15:11.481547+00:00
- unpaywall
- last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-NC-4.0